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Abstract
Introduction: Vascular spinal cord injury following coronary bypass grafting surgery is very rare
and this is probably one of few reports of a presumptive partial conus medullaris lesion leading to
sudden onset bladder and bowel incontinence which was managed using duloxetine, a selective
serotonin and norepinephrine reuptake inhibitor. Duloxetine has been used in selected patients
with post-prostatectomy sphincteric incontinence but not, to our knowledge, for spinal vascular
lesions.
Case presentation: A 63-year-old Indian man developed bladder and bowel incontinence
immediately following coronary bypass grafting surgery. Findings were suggestive of
microcirculatory partial conus medullaris infarction. Based on his urodynamics findings he was
managed with duloxetine, tolterodine and clean intermittent catheterization. The clinical
presentation, serial urodynamic findings and implications are discussed.
Conclusion: Spinal injury following coronary bypass grafting is rare and devastating. It is important
to be able to recognize the problem even when paraplegia is not noted, counsel the patient and
manage the patient with the help of urodynamics. In patients with sphincteric incontinence,
duloxetine may have a role in management.
Introduction
Vascular spinal cord injury following coronary artery
bypass grafting surgery (CABG) is very rare [1,2] and this
is probably one of few reports of a presumptive conus
medullaris lesion leading to sudden onset bladder and
bowel incontinence. Our patient was managed using
duloxetine, a selective serotonin and norepinephrine
reuptake inhibitor with clean intermittent self catheteriza-
tion (CISC). Duloxetine has been used for post-prostatec-
tomy incontinence in men and is approved for female
stress urinary incontinence in many countries [3]. The
drug works by increasing the rhabdosphincter tone via a
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spinal cord mediated action [3]. To our knowledge, there
is no literature on the use of duloxetine for neurogenic
sphincteric male urinary incontinence.
Case Presentation and Management
A 63y hypertensive, non-smoker male underwent CABG
in July 2004. He was non-diabetic, had no prior neurolog-
ical problems and had a normal lipid profile. He had mild
urinary frequency prior to CABG. Immediately following
CABG he developed both bladder and bowel inconti-
nence. Ultrasonographic examination showed 150 ml
urine in the bladder with inability to void suggesting a pic-
ture of overflow incontinence albeit with a reduced capac-
ity. He had profound laxity of anal sphincter, distended
rectum with stool impaction, impaired perianal sensation
and absent bulbocavernosal reflex but no lower limb neu-
rological symptoms. There was isolated bladder and
bowel involvement without a well defined spinal shock.
Lower limb reflexes were intact and normal. Spinal MR
imaging did not show any abnormality. The clinical find-
ings were consistent with probable microcirculatory
ischemic infarction of the conus medullaris region leading
to partial and selective denervation.
He had recurrent retention for which he underwent uro-
dynamics evaluation at 4 months. This showed mild
reduction in compliance, no phasic contractions, and leak
after 225 ml filling at a detrusor leak point pressure of 19
cm H20. He had severe incontinence with any rise in
abdominal pressure suggesting low sphincteric resistance
(Figure 1). He was unable to empty the bladder effectively
on a Crede's maneuver and was started on CISC, tolterod-
ine and imipramine. He continued to have urinary incon-
tinence between catheterizations. He was then started on
duloxetine 40 mg twice daily along with tolterodine. This
resulted in complete resolution of his incontinence,
increase in average CISC volumes from 150 ml to 280 ml,
with marked improvement in urodynamics parameters
(Figure 2).
At 5 years followup the patient continues CISC and med-
ication and is doing well.
Discussion
Conus medullaris ischemia and infarction with profound
loss of anal sphincter tone and bowel and bladder incon-
tinence [4] has been reported following aortic surgery due
to intraoperative insult to vascular supply [5]. The clinical
Initial urodynamics study Figure 1
Initial urodynamics study. Urodynamic study prior to duloxetine (Nov 2004, 4 months after onset) done in lying down posi-
tion (since the patient had a very lax anal sphincter). There was severe leak (L) noted on minimal abdominal straining. Continu-
ous pericatheter leak was noted at 225 ml at a pressure of 19 cm H20. He had an acontractile detrusor.Cases Journal 2009, 2:9094 http://www.casesjournal.com/content/2/1/9094
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presentation of this patient strongly suggests the occur-
rence of microcirculatory partial conus medullaris infarc-
tion. Microcirculatory infarction is well known in a post
operative setting and may not be identifiable on conven-
tional imaging [2].
Duloxetine is approved for use in men for its neuropsychi-
atric effects [6]. Conceptually, the rhabdosphincter effects
of duloxetine seen in women should be reproducible in
men. Increased serotonin and norepinephrine availability
due to duloxetine has been shown in healthy volunteer
men at clinical dosages [7]. In fact, retention has been
reported in men using the drug for psychiatric indications
[6]. In our patient tolterodine was used along with
duloxetine to reduce the storage bladder pressures and
improve functional bladder capacity. The safety of this
combination has already been documented and no dos-
age adjustments are necessary [8]. There are initial reports
on the use of duloxetine for post-prostatectomy male uri-
nary incontinence [9]. Duloxetine was found to be effec-
tive but there were significant side effects necessitating
stoppage of drug in 6 out of the 20 patients studied. In our
patient with a neurogenic male sphincteric incontinence,
presumably the duloxetine worked by increasing the tone
of the external rhabdosphincter by increasing neurotrans-
mitter availability. This might have been possible because
the patient had a partial conus lesion. Future studies are
needed to evaluate the use of this drug in neurogenic male
sphincteric incontinence to identify whether the drug
would be effective in all forms of neurogenic sphincteric
incontinence or only in select patients with incomplete
lesions.
Conclusion
Spinal injury following CABG is very rare. It is important
to be able to recognize lower urinary tract dysfunction
even when paraplegia is not noted, counsel the patient
and manage the patient with the help of urodynamics. In
patients with neurogenic sphincteric incontinence,
duloxetine may have a role in management.
Institutional ethics committee approval was taken prior to
use of duloxetine in this patient.
Follow up urodynamics study Figure 2
Follow up urodynamics study. Follow up urodynamic study after commencing 40 mg twice daily Duloxetine (Aug 2005). 
Patient also on tolterodine sustained release 4 mg once daily. No leak was observed on cough (C) or valsalva (V) and there was 
no pericatheter leak on filling beyond 400 ml (not depicted; separate cycle of filling).Publish with BioMed Central    and   every 
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